Showing 1 - 1 of 1 Items
Showing 1 - 1 of 1 Items
Sort By: Relevance
Journal Article
|Review
2018-05-22 • British Journal of Clinical Pharmacology
2018-05-22 • British Journal of Clinical Pharmacology
AIMS
Efavirenz (EFV) and rifampicin-isoniazid (RH) are cornerstone drugs in human immunodeficiency virus (HIV)-tuberculosis (TB) coinfection treatment but with complex drug interacti...
Efavirenz (EFV) and rifampicin-isoniazid (RH) are cornerstone drugs in human immunodeficiency virus (HIV)-tuberculosis (TB) coinfection treatment but with complex drug interacti...